Company Summary
Search
Home Page
 
*Protox Therapeutics Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31DelistN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
1/Sep/1999 19/May/2003 Canada British Columbia  
20/May/2003 3/Feb/2008 Canada  Amalgamation 
Exchange Filing Office
Location
(not available)
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  *Biotechnology/Biopharmaceutical  (not available) 
  *Capital Pool Company  (not available) 
Securities
SymbolSecurity NameMarketStatus
*PRX*Protox Therapeutics Inc.TSX VentureDELIST
*SNB.P*SNB Capital Corp.TSX VentureDELIST
*NUC.P*Nucleus Bioscience Inc.TSX VentureDELIST
*NUC*Nucleus Bioscience Inc.TSX VentureDELIST
Name HistoryFromTo
*Protox Therapeutics Inc.14/Jul/20043/Feb/2008
*SNB Capital Corporation19/Jun/200313/Jul/2004
*Nucleus BioScience Inc.4/Jul/200018/Jun/2003
Company Facts Reconciliation
SubjectDate Returned
Summer 2007 CFRNot Received
Associations
Auditing Firm:  *PricewaterhouseCoopers LLP
  *Ernst & Young LLP (Vancouver)
Investor Relations:  *Equicom Group Inc
  *Terry Vanderkruyk
Law Firm:  *Fasken Martineau DuMoulin LLP
  *Catalyst Corporate Finance Lawyers
Sponsor:  *Canaccord Genuity Corp.
Subsidiary:  *Protox Pharmaceuticals Inc.
Transfer Agent:  *Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  30/Jan/2008  NEWS RELEASE - TO GRADUATE TO TORONTO STOCK EXCHANGE[MARKET NEWS]
    NEWS RELEASE - PROTOX TO GRADUATE TO TORONTO STOCK EXCHANGE[CANADA NEWSWIRE]
    NEWS RELEASE - INITIATES PHASE 2 PROSTATE CANCER STUDY[MARKET NEWS]
Bulletins  1/Feb/2008  Graduation
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data